Cargando…
Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
2-Ethyl-6-methyl-3-hydroxypyridine succinate (EMHPS, Mexidol) is an original antioxidant and an anti-ischemic drug with the possibility of wide applications in the complex therapy of diseases, accompanied by the development of oxidative stress and ischemia; for example, ischemic stroke, chronic cere...
Autores principales: | Shchulkin, Aleksey V., Erokhina, Pelageya D., Goncharenko, Anna V., Mylnikov, Pavel Yu., Chernykh, Ivan V., Abalenikhina, Yulia V., Kotliarova, Maria S., Yakusheva, Elena N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674565/ https://www.ncbi.nlm.nih.gov/pubmed/38004395 http://dx.doi.org/10.3390/ph16111529 |
Ejemplares similares
-
Mechanisms of P-Glycoprotein Regulation Under Exogenous and Endogenous Oxidative Stress In Vitro
por: Abalenikhina, Yu. V., et al.
Publicado: (2022) -
Therapeutic Drug Monitoring in Arterial Hypertension
por: Seleznev, Sergey, et al.
Publicado: (2023) -
Correction of Experimental Retinal Ischemia by l-Isomer of Ethylmethylhydroxypyridine Malate
por: Peresypkina, Anna, et al.
Publicado: (2019) -
An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure
por: Vandell, A G, et al.
Publicado: (2018) -
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates
por: Gupta, Pranav, et al.
Publicado: (2019)